646 related articles for article (PubMed ID: 33087136)
1. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
3. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
[TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
5. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
[TBL] [Abstract][Full Text] [Related]
6. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
7. The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response.
Zhao X; Zhuang Y; Wang B; Yuan B; Du S; Zeng Z
Radiat Res; 2023 Jan; 199(1):48-60. PubMed ID: 36445955
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
9. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing DNA damage-dependent cell cycle arrest.
Li QZ; Chen YY; Liu QP; Feng ZH; Zhang L; Zhang H
Phytomedicine; 2024 Apr; 126():155177. PubMed ID: 38412667
[TBL] [Abstract][Full Text] [Related]
12. Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T.
Wang F; Zhong S; Mao C; Jin J; Wang H
Ann Hepatol; 2022; 27(5):100722. PubMed ID: 35569812
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of
Shen L; Zhao K; Li H; Ning B; Wang W; Liu R; Zhang Y; Zhang A
Epigenomics; 2019 Aug; 11(11):1283-1305. PubMed ID: 31355678
[No Abstract] [Full Text] [Related]
14. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
15. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance 3 promotes hepatocellular carcinoma radioresistance by activating the NF-κB pathway.
Yang Q; Xie B; Tang H; Meng W; Jia C; Zhang X; Zhang Y; Zhang J; Li H; Fu B
J Exp Clin Cancer Res; 2019 Jun; 38(1):263. PubMed ID: 31208444
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
[TBL] [Abstract][Full Text] [Related]
18. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
[TBL] [Abstract][Full Text] [Related]
19. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
Zhou ZQ; Zhao JJ; Chen CL; Liu Y; Zeng JX; Wu ZR; Tang Y; Zhu Q; Weng DS; Xia JC
Mol Carcinog; 2019 Jan; 58(1):76-87. PubMed ID: 30182378
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
